Three African nations roll out first malaria vaccine in closely watched trial
Progress against malaria has stalled in recent years, with resistance to treatment growing and a global drop in cases leveling off.
Related Articles
Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug
Gilead will license the HIV drug lenacapavir, a twice-yearly injectable, to six generic makers for 120 countries.
Was Missouri’s bird flu case a one-off or something more? Quest for answers faces testing delay
U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird flu passed the virus on…
Lawmakers want FTC to probe big PBMs over private-label biosimilar deals
A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients are being steered…
Q&A: AI is coming for lots of jobs. What about that of the cancer researcher?
Is Sam Altman right in suggesting an AI will replace the PI in cancer research? It comes down to the nature of creative thinking, says…
Brain-computer interfaces are rapidly evolving. Here are six scientists shaping the field
After demonstrating safety, the brain-computer interface field is now poised to leap from the lab to the real world.
Sammy Basso, progeria advocate, has died at 28
We generally don’t think of rare-disease advocacy as funny. But Sammy Basso, who died at 28, will be remembered for his ability to find laughter…
Congress can prevent deaths from cardiac arrest if it acts now
The CEO of the American Heart Association urges Congress to prevent deaths from cardiac arrest by passing the HEARTS Act.
$400 million for an obesity drug startup? A new venture is a sign of the times
Atlas Venture and Bain Capital Life Sciences are making their next bet in the buzzy obesity field, launching a new startup led by an executive…
What Kaiser Permanente learned from using Apple Watch tech in Parkinson’s care
Since late 2023, Kaiser has been giving some of its Parkinson’s patients an Apple Watch app called StrivePD, developed by Rune Labs.
Health care CEOs dialed back their pay in 2023. They still made $3.5 billion
Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs even lost their bonuses. But